Austrian JS, Adelman JS, Reissman SH, et al. The impact of the heparin-induced thrombocytopenia (HIT) computerized alert on provider behaviors and patient outcomes

Department of Medicine, NYU Langone Medical Center, New York 10010, USA.
Journal of the American Medical Informatics Association (Impact Factor: 3.5). 06/2011; 18(6):783-8. DOI: 10.1136/amiajnl-2011-000138
Source: PubMed


The aim of this study was to measure the effect of an electronic heparin-induced thrombocytopenia (HIT) alert on provider ordering behaviors and on patient outcomes.
A pop-up alert was created for providers when an individual's platelet values had decreased by 50% or to <100,000/mm(3) in the setting of recent heparin exposure. The authors retrospectively compared inpatients admitted between January 24, 2008 and August 24, 2008 to a control group admitted 1 year prior to the HIT alert. The primary outcome was a change in HIT antibody testing. Secondary outcomes included an assessment of incidence of HIT antibody positivity, percentage of patients started on a direct thrombin inhibitor (DTI), length of stay and overall mortality.
There were 1006 and 1081 patients in the control and intervention groups, respectively. There was a 33% relative increase in HIT antibody test orders (p=0.01), and 33% more of these tests were ordered the first day after the criteria were met when a pop-up alert was given (p=0.03). Heparin was discontinued in 25% more patients in the alerted group (p=0.01), and more direct thrombin inhibitors were ordered for them (p=0.03). The number who tested HIT antibody-positive did not differ, however, between the two groups (p=0.99). The length of stay and mortality were similar in both groups.
The HIT alert significantly impacted provider behaviors. However, the alert did not result in more cases of HIT being detected or an improvement in overall mortality. Our findings do not support implementation of a computerized HIT alert.

Download full-text


Available from: Hillel W Cohen
  • Source
    • "The most commonly used type of proxy measure in this group was process measures that were associated with adverse events. Of the studies that solely used proxy measures, 52.9% reported this type of measure [15-17,22,25,26,28,30,32,34],[41-43,46,50-54,60,61,66,67,70],[73,74,76-78,80,85-87,89,90]. Examples of other proxy measures reported by these studies included rates of adverse events (reported by 39.7% of studies [16-19,23,25,26,39,40,43,45-47],[53-55,57-59,63,65,67,69,72,73],[79,90]), length of stay (reported by 22.1% of studies [15,19,31,38,44,45,47,49],[57,63,66,67,72,81,82]), resource utilization metrics (reported by 16.2% of studies [13,14,29,38,48,56,75,81],[82,86,88]) and patient charges (reported by 5.9% of studies [21,27,83,84]). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Healthcare costs are increasing rapidly and at an unsustainable rate in many countries, and inpatient hospitalizations are a significant driver of these costs. Clinical decision support (CDS) represents a promising approach to not only improve care but to reduce costs in the inpatient setting. The purpose of this study was to systematically review trials of CDS interventions with the potential to reduce inpatient costs, so as to identify promising interventions for more widespread implementation and to inform future research in this area. To identify relevant studies, MEDLINE was searched up to July 2013. CDS intervention studies with the potential to reduce inpatient healthcare costs were identified through titles and abstracts, and full text articles were reviewed to make a final determination on inclusion. Relevant characteristics of the studies were extracted and summarized. Following a screening of 7,663 articles, 78 manuscripts were included. 78.2% of studies were controlled before-after studies, and 15.4% were randomized controlled trials. 53.8% of the studies were focused on pharmacotherapy. The majority of manuscripts were published during or after 2008. 70.5% of the studies resulted in statistically and clinically significant improvements in an explicit financial measure or a proxy financial measure. Only 12.8% of the studies directly measured the financial impact of an intervention, whereas the financial impact was inferred in the remainder of studies. Data on cost effectiveness was available for only one study. Significantly more research is required on the impact of clinical decision support on inpatient costs. In particular, there is a remarkable gap in the availability of cost effectiveness studies required by policy makers and decision makers in healthcare systems.
    Full-text · Article · Dec 2013 · BMC Medical Informatics and Decision Making
  • Source
    • "Workflow has emerged as an area of focus [17]. Work continues to iteratively improve CPOE systems with clinical decision support alerts to further reduce medication errors and improve prescriber adherence to guidelines [18] [19] [20]. One of the major barriers to the adoption of CPOE (and EHRs) has long been the large up-front investment. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Computerized provider order entry (CPOE) is the process of entering physician orders directly into an electronic health record. Although CPOE has been shown to improve medication safety and reduce health care costs, these improvements have been demonstrated largely in the inpatient setting; the cost-effectiveness in the ambulatory setting remains uncertain. Objective The objective was to estimate the cost-effectiveness of CPOE in reducing medication errors and adverse drug events (ADEs) in the ambulatory setting. Methods We created a decision-analytic model to estimate the cost-effectiveness of CPOE in a midsized (400 providers) multidisciplinary medical group over a 5-year time horizon— 2010 to 2014—the time frame during which health systems are implementing CPOE to meet Meaningful Use criteria. We adopted the medical group’s perspective and utilized their costs, changes in efficiency, and actual number of medication errors and ADEs. One-way and probabilistic sensitivity analyses were conducted. Scenario analyses were explored. Results In the base case, CPOE dominated paper prescribing, that is, CPOE cost $18 million less than paper prescribing, and was associated with 1.5 million and 14,500 fewer medication errors and ADEs, respectively, over 5 years. In the scenario that reflected a practice group of five providers, CPOE cost $265,000 less than paper prescribing, was associated with 3875 and 39 fewer medication errors and ADEs, respectively, over 5 years, and was dominant in 80% of the simulations. Conclusions Our model suggests that the adoption of CPOE in the ambulatory setting provides excellent value for the investment, and is a cost-effective strategy to improve medication safety over a wide range of practice sizes.
    Full-text · Article · May 2013 · Value in Health
  • Source

    Preview · Article · Oct 2011 · Journal of the American Medical Informatics Association
Show more